A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome.

Khalilian, Alireza; Ahmadimoghaddam, Davoud; Saki, Shiva; Mohammadi, Younes; Mehrpooya, Maryam

Khalilian, Alireza; Ahmadimoghaddam, Davoud; Saki, Shiva; Mohammadi, Younes; Mehrpooya, Maryam.

Afiliación

Khalilian A; Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Ahmadimoghaddam D; Department of Pharmacology & Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
Saki S; Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran.
Mohammadi Y; Modeling of Noncommunicable Diseases Research Center, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Mehrpooya M; Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Shahid Fahmideh Ave, Hamadan, 6517838678, Iran. m_mehrpooya2003@yahoo.com.

Biopsychosoc Med ; 15(1): 3, 2021 Feb 03.

Article en En | MEDLINE | ID: mdl-33536043

Palabras clave

5-hydroxytryptamine; Diarrhea; Irritable bowel syndrome; Mirtazapine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Biopsychosoc Med Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google